DOI: 10.1055/s-00000025

Hormone and Metabolic Research


Gee J, Bailey H, Kim K, Kolesar J, Havighurst T, Tutsch KD, See W, Cohen MB, Street N, LeVan L.
Phase II open label, multi-center clinical trial of modulation of intermediate endpoint biomarkers by 1α-hydroxyvitamin D2 in patients with clinically localized prostate cancer and high grade pin.

Prostate 2013;
73: 970-978

Download Bibliographical Data

Search in: